Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2018106921) ESSENTIAL NUTRIENTS AND RELATED METHODS
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2018/106921 International Application No.: PCT/US2017/065118
Publication Date: 14.06.2018 International Filing Date: 07.12.2017
IPC:
A61P 25/00 (2006.01) ,A61P 9/00 (2006.01) ,A61K 36/05 (2006.01) ,A61K 31/202 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
25
Drugs for disorders of the nervous system
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
9
Drugs for disorders of the cardiovascular system
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36
Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
02
Algae
05
Chlorophycota or chlorophyta (green algae), e.g. Chlorella
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
185
Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
19
Carboxylic acids, e.g. valproic acid
20
having a carboxyl group bound to an acyclic chain of seven or more carbon atoms, e.g. stearic, palmitic or arachidic acid
202
having three or more double bonds, e.g. linolenic acid
Applicants:
BALCHEM CORPORATION [US/US]; 52 Sunrise Park Road New Hampton, New York 10958, US
Inventors:
BORTZ, Jonathan David; US
Agent:
DOTY, Kathryn J.; US
RILEY-VARGAS, Rebecca; US
Priority Data:
62/432,46809.12.2016US
Title (EN) ESSENTIAL NUTRIENTS AND RELATED METHODS
(FR) NUTRIMENTS ESSENTIELS ET PROCÉDÉS ASSOCIÉS
Abstract:
(EN) The present disclosure relates to pharmaceutical compositions for mammalian consumption containing essential fatty acids, protein, vitamins and choline, or combinations thereof, so constituted to optimize absorption and/or transport and/or efficiency of the co-ingredients of the composition. The pharmaceutical compositions are useful as supplements to provide nutrients to nutritionally deficient patients. The composition can contain essential fatty acids, such as EPA, DHA and/or ALA, cobalamin binding protein, such as Intrinsic Factor, vitamin B12 or a synthetic form thereof, choline, such as choline bitartrate, or combinations thereof.
(FR) La présente invention concerne des compositions pharmaceutiques destinées à la consommation par des mammifère contenant des acides gras essentiels, des protéines, des vitamines et de la choline, ou des combinaisons de ceux-ci, constituées de façon à optimiser l'absorption et/ou le transport et/ou l'efficacité des co-ingrédients de la composition. Les compositions pharmaceutiques sont utiles en tant que suppléments pour apporter des nutriments à des patients présentant un déficit nutritionnel. La composition peut contenir des acides gras essentiels, tels que l'EPA, le DHA et/ou l'ALA, la protéine de liaison à la cobalamine, par exemple le facteur intrinsèque, la vitamine B12 ou une forme synthétique de celle-ci, la choline, par exemple sous forme de bitartrate de choline, ou des combinaisons de ceux-ci.
front page image
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)